Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Self-Certification For Trial Coverage Will Be Easy, Says CMS

This article was originally published in The Gray Sheet

Executive Summary

CMS is trying to make it simple for clinical trial sponsors and investigators to get reimbursed by Medicare for routine costs

You may also be interested in...



Duke Studying Impact Of Clinical Trial Coverage On Enrollment For CMS

With anecdotal evidence suggesting that issues surrounding insurance coverage for clinical trial treatments may hamper study participation, CMS has contracted with Duke University to conduct a more systematic evaluation of the issue

Duke Studying Impact Of Clinical Trial Coverage On Enrollment For CMS

With anecdotal evidence suggesting that issues surrounding insurance coverage for clinical trial treatments may hamper study participation, CMS has contracted with Duke University to conduct a more systematic evaluation of the issue

Industry Digs Into Specifics Of CMS Proposal For Covering Clinical Trial Costs

Device industry representatives say CMS' latest proposed revision of its policy for covering certain clinical trial costs is a significant improvement over the previous proposal, but claim some specific requirements would be too burdensome on manufacturers

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel